Abstract
This paper aimed to examine the literature for cases of coronary artery stent infection in order to provide comprehensive data to clinicians regarding its prevalence, clinical presentations, and possible treatments. Coronary artery stenting was initially reported in 1987. Stenting of the coronary arteries is now used in 40–60% of all interventional coronary artery procedures. The understanding of the pathophysiology of coronary artery disease is evolving. It has been suggested that atherosclerosis may be a complication of an infectious etiology. By using a stent to treat coronary artery disease, a foreign body is directly juxtaposed with an area of inflammation. The first reported case of an infected coronary artery stent was in 1993. Although this is an exceedingly rare event, the associated mortality is alarmingly high. Analysis of the literature reveals a total of four reported cases of coronary artery stent infection. Symptoms of stent infection present days to weeks after the initial coronary intervention. All four patients developed fevers and at least two patients developed postintervention angina. In patients who have had a coronary artery stented, the presence of angina and fevers should make the clinician suspicious for a stent‐related infection. Two of the patients had infection with Pseudomonas aeruginosa, which seems to be an unusual organism for a catheter‐related infection. Surgical removal of the infected stent and artery complex was performed on nearly all cases. Despite aggressive measures, the majority of patients died. Few data are available on the long‐term risk for coronary artery stent infection. In a patient who has undergone coronary artery stent placement, the clinician must be very sensitive to fever, return of angina, and bacteremia. The complication rate at the present time does not warrant the use of prophylactic antibiotics prior to high‐risk procedures (e.g., dental procedures). Furthermore, the low infection rate of coronary artery stents may be a result of the inflammatory nature of atherosclerosis, which may provide a protective benefit against bacterial infection of the stent.
Keywords: stent, infection, coronary artery, complication
Full Text
The Full Text of this article is available as a PDF (324.7 KB).
References
- 1. Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberger L: Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 1987; 316: 701–706 [DOI] [PubMed] [Google Scholar]
- 2. Marso SP, Ellis SG, Raymond R. Intracoronary stenting : An overview for the clinician. Clev Clin J Med 1999; 66: 434–442 [DOI] [PubMed] [Google Scholar]
- 3. Haase KK, Baumbah A, Karsch KR: Stents are used too often. Heart 1998; 79: 541–542 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Dieter RS: Vascular adhesion molecules. Contemp Surg 1998; 52: 374 [Google Scholar]
- 5. Leroy O, Martin E, Prat A, Decoulx E, Georges H, Guilley J, Beuscart C, Beaucaire G: Fatal infection of coronary artery stent implantation. Cathet Cardiovasc Diagn 1996; 39: 168–170 [DOI] [PubMed] [Google Scholar]
- 6. McCready RA, Siderys H, Pittman JN, Herod GT, Halbrook HG, Fehrenbacher JW, Beckman DJ, Hormuth DA: Septic complications after cardiac catheterization and percutaneous transluminal coronary angioplasty. J Vase Surg 1991; 14: 170–174 [DOI] [PubMed] [Google Scholar]
- 7. Timsit JF, Wolff MA, Bedos JP, Lucet JC, Deere D: Cardiac abscess following percutaneous transluminal coronary angioplasty. Chest 1993; 103: 639–641 [DOI] [PubMed] [Google Scholar]
- 8. Dieter RS, Shah P, Dieter RA: Infected aortic pseudo‐aneurysm complicating coronary stent placement (abstr). XXXII International College of Surgeons, Singapore, 2000. [Google Scholar]
- 9. James E, Broadhurst P, Simpson A, Das S: Bacteraemia complicating coronary artery stenting. J Hosp Infect 1998; 38: 154–155 [DOI] [PubMed] [Google Scholar]
- 10. Bouchart F, Dubar A, Bessou JP, Redonnet M, Berland J, Mouton‐Schleifer D, Haas‐Hubscher C, Soyer R: Pseudomonas aeruginosa coronary stent infection. Ann Thorac Surg 1997; 64: 1810–1813 [DOI] [PubMed] [Google Scholar]
- 11. Shea KW, Schwartz RK, Gambino AT, Marzo KP, Cunha BA: Bacteremia associated with percutaneous transluminal coronary angioplasty. Cathet Cardiovasc Diagn 1995; 36: 5–9 [DOI] [PubMed] [Google Scholar]
- 12. Sande MA, Levinson ME, Lukas DS, Kaye D: Bacteremia associated with cardiac catheterization. N Engl J Med 1969; 281: 1104–1106 [DOI] [PubMed] [Google Scholar]
- 13. Malanoski GJ, Samore MH, Pefanis A, Karchmer AW: Staphylococcus aureus catheter‐associated bacteremia. Minimal effective therapy and unusual infectious complications associated with arterial sheath catheters. Arch Intern Med 1995; 155: 1161–1166 [DOI] [PubMed] [Google Scholar]
- 14. Hearn AT, James KV, Lohr JM, Thibodeaux LC, Roberts WH, Welling RE: Endovascular stent infection with delayed bacterial challenge. Am J Surg 1997; 174: 157–159 [DOI] [PubMed] [Google Scholar]
- 15. Sharis PJ, Cannon CP, Loscalzo J: The antiplatelet effects of ticlopidine and clopidogrel. Ann Intern Med 1998; 129: 394–405 [DOI] [PubMed] [Google Scholar]
- 16. Berger PB, Bell MR, Hasdai D, Grill DE, Melby S, Holmes DR: Safety and efficacy of ticlopidine for only 2 weeks after successful intracoronary stent placement. Circulation 1999; 99: 248–253 [DOI] [PubMed] [Google Scholar]
- 17. Grewe PH, Machraoui A, Deneke T, Muller KM: Suppurative pancarditis: A lethal complication of coronary stent implantation. Heart 1999; 81: 559 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Gunther HU, Strupp G, Volmar J, v.Korn H, Bonzel T, Stegmann T: Coronary stent implantation: Infection and abscess with fatal outcome. Z Kardiol 1993; 82: 521–525 [PubMed] [Google Scholar]